Purchase Order 75N94023P00556
Award Date 7/24/23
Potential Completion Date 9/30/23
Potential Value $28K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $24,948.00 firm fixed price purchase order is for a complex lipid panel analysis of 56 samples. The contract has no set-aside designation. Metabolon is a leading provider of specialized metabolomics analysis services, leveraging its proprietary platforms to support a wide range of federal...
- This is a $17,000 federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a small disadvantaged business, for metabolite analysis services. The contract is not set aside. Metabolon is a leading provider of metabolomics solutions that leverages proprietary technology to identify and quantify metabolites from biological samples. This contract supports NIDDK's research initiatives, such as the analysis of serum...
- This is a federal contract award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for $21,600.00. The contract is for the acquisition of metabolic profiling of mouse livers. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. The company has served as...
- The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), awarded a sole-source contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic analysis services. The $28,991.20 firm-fixed-price purchase order is to support the Liver Diseases Branch's research on microbiomes and their effects on host physiology and immune responses. Metabolon will use ultra-high performance liquid chromatography...
- This federal contract award to Metabolon, Inc., a self-certified small disadvantaged business, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $9,000 firm fixed-price purchase order does not have a set-aside designation. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. This award...
- This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- Metabolon, Inc. was awarded a $44,775 purchase order contract by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide unspecified services or products. The contract is a firm fixed price agreement that will be performed in Research Triangle Park, North Carolina over approximately 15 months from February 2018 through May 2019. No additional details were provided regarding the original solicitation or scope of work. Metabolon, Inc. is...
- This is a $24,300 firm fixed-price purchase order awarded by a civilian federal agency to Metabolon, Inc., a self-certified small disadvantaged business, for metabolite profile processing services. The contract has no set-aside designation and is scheduled for completion by November 30, 2020. Metabolon is a leading provider of specialized metabolomics services and solutions to various federal agencies, offering advanced analytical capabilities in metabolite identification and quantification. The...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $994,520 contract is for dietary biomarker development work in support of three NCI-funded studies: the Interactive Diet and Activity Tracking in AARP (IDATA) Study, the Women's Alcohol Study (WAS), and the Golestan Cohort Study (GCS). This award supports Metabolon's specialized metabolomics analysis...